haloperidol has been researched along with Dystonia in 112 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Randomised controlled trials (RCTs) involving people exhibiting aggression and/or agitation thought to be due to psychosis, allocated rapid use of haloperidol alone (by any route), compared with any other treatment." | 8.95 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Brooke-Powney, MJ; Li, X; Ostinelli, EG, 2017) |
| "To evaluate the clinical effects of haloperidol for the management of schizophrenia and other similar serious mental illnesses compared with placebo." | 8.89 | Haloperidol versus placebo for schizophrenia. ( Adams, CE; Bergman, H; Irving, CB; Lawrie, S, 2013) |
| "Randomised controlled trials (RCTs) involving people exhibiting agitation or aggression (or both) thought to be due to psychosis, allocated rapid use of haloperidol alone (by any route), compared with any other treatment." | 8.88 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Jones, H; Powney, MJ, 2012) |
| "A 28-year-old woman presenting with agitation and mania with psychotic features developed symptoms of isolated lingual dystonia shortly after the initiation of a haloperidol concentrate regimen." | 8.02 | Haloperidol-induced isolated lingual dystonia. ( Chapa, A; Helminiak, A; Jin, JW; Kockara, N, 2021) |
| " He had relapse symptoms of schizophrenia and had recently received a single dose of parenteral haloperidol to manage his agitation." | 7.85 | Persistent oromandibular dystonia and angioedema secondary to haloperidol. ( Masiran, R, 2017) |
| "We discus the case of a forty-nine year old patient with haloperidol induced laryngeal dystonia (LD)." | 7.74 | A patient with haloperidol induced laryngeal dystonia. ( Peek, DF, 2008) |
| "To report a case of delayed-onset dystonic reactions, oculogyric crisis (OGC), and torticollis after treatment with intramuscular haloperidol lactate injection." | 7.72 | Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. ( Jhee, SS; Mohaupt, SM; Sims, SJ; Yones, CL; Zarotsky, V, 2003) |
| " Therefore, we have studied the effect of different 5-HT drugs and one anticholinergic drug in acute dystonia in five cebus monkeys chronically treated with haloperidol." | 7.67 | Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys. ( Gerlach, J; Korsgaard, S; Laursen, AL; Noring, U; Povlsen, UJ, 1986) |
| "The use of baclofen, a structural analog of gamma-aminobutyric acid (GABA), is described in the treatment of a patient with tardive dystonia." | 7.67 | Baclofen treatment in a patient with tardive dystonia. ( Allen, A; Lux, WE; Rosse, RB, 1986) |
| "Then at the age of eight, she developed dystonia of the left lower extremity that became noticeable toward evening but subsided after taking sleep." | 5.28 | [Response to haloperidol and analysis of growth curve in hereditary progressive dystonia with marked diurnal fluctuation]. ( Cho, K; Kusunoki, Y; Oki, J; Sasaki, N, 1989) |
| "Sixty-two first-episode psychotic patients who were neuroleptic-naive were studied to examine predictors of acute dystonia after treatment with haloperidol." | 5.07 | Predictors of acute dystonia in first-episode psychotic patients. ( Aguilar, EJ; Gómez-Beneyto, M; Hernández, J; Keshavan, MS; Martínez-Quiles, MD; Schooler, NR, 1994) |
| "Randomised controlled trials (RCTs) involving people exhibiting aggression and/or agitation thought to be due to psychosis, allocated rapid use of haloperidol alone (by any route), compared with any other treatment." | 4.95 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Brooke-Powney, MJ; Li, X; Ostinelli, EG, 2017) |
| "To evaluate the clinical effects of haloperidol for the management of schizophrenia and other similar serious mental illnesses compared with placebo." | 4.89 | Haloperidol versus placebo for schizophrenia. ( Adams, CE; Bergman, H; Irving, CB; Lawrie, S, 2013) |
| "Randomised controlled trials (RCTs) involving people exhibiting agitation or aggression (or both) thought to be due to psychosis, allocated rapid use of haloperidol alone (by any route), compared with any other treatment." | 4.88 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Jones, H; Powney, MJ, 2012) |
| "Clinical safety data for treatment of acute schizophrenia with olanzapine, a new atypical antipsychotic agent, are summarized." | 4.79 | Safety of olanzapine. ( Beasley, CM; Tollefson, GD; Tran, PV, 1997) |
| "A 28-year-old woman presenting with agitation and mania with psychotic features developed symptoms of isolated lingual dystonia shortly after the initiation of a haloperidol concentrate regimen." | 4.02 | Haloperidol-induced isolated lingual dystonia. ( Chapa, A; Helminiak, A; Jin, JW; Kockara, N, 2021) |
| " When the diagnosis of haloperidol-induced acute dystonia was made, 3 mg of intravenous biperiden was promptly administered with complete clinical resolution in 15 min." | 3.91 | Involuntary movements in an adolescent: what are the causes? ( Brito, N; Fernandes, A; Moura, L; Vaz, AS, 2019) |
| " He had relapse symptoms of schizophrenia and had recently received a single dose of parenteral haloperidol to manage his agitation." | 3.85 | Persistent oromandibular dystonia and angioedema secondary to haloperidol. ( Masiran, R, 2017) |
| "We discus the case of a forty-nine year old patient with haloperidol induced laryngeal dystonia (LD)." | 3.74 | A patient with haloperidol induced laryngeal dystonia. ( Peek, DF, 2008) |
| "To report a case of delayed-onset dystonic reactions, oculogyric crisis (OGC), and torticollis after treatment with intramuscular haloperidol lactate injection." | 3.72 | Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. ( Jhee, SS; Mohaupt, SM; Sims, SJ; Yones, CL; Zarotsky, V, 2003) |
| "Although diphenhydramine hydrochloride is known to eliminate or reduce the symptoms of dystonia in human patients with acute dystonic reactions and idiopathic torsion dystonia, its mechanism of action is still unclear." | 3.69 | Evidence for the involvement of histamine in the antidystonic effects of diphenhydramine. ( Matsumoto, RR; Stone, MR; Truong, DD; van't Groenewout, JL; Vo, VN, 1995) |
| " Recent studies in mutant dystonic hamsters (dt[sz]), an animal model of idiopathic generalized dystonia, revealed antidystonic effects of both N-methyl-D-aspartate (NMDA) receptor antagonists, such as dizocilpine (MK-801), and of neuroleptics, such as haloperidol and clozapine." | 3.69 | MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamsters. ( Löscher, W; Richter, A, 1997) |
| "The patient was a 24-year-old man with recently diagnosed schizophrenia who presented twice to a general hospital with difficulty speaking within 72 hours of increasing his dose of haloperidol." | 3.69 | Neuroleptic-induced laryngeal dystonia can mimic anaphylaxis. ( Ilchef, R, 1997) |
| "To examine whether acute dystonia is induced by neuroleptic treatment, common marmosets were treated with haloperidol orally twice a week over 25 weeks until dystonic behavior was elicited." | 3.69 | The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia. ( Fukuoka, T; Kohda, A; Matsuo, M; Nakano, M; Okuno, Y, 1997) |
| "The effects of the atypical neuroleptic clozapine were studied in an inbred line of Syrian golden hamsters with generalized dystonia, i." | 3.68 | The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol. ( Löscher, W; Richter, A, 1993) |
| " The dopamine precursor levodopa (injected together with carbidopa) and the dopamine receptor agonist apomorphine increased the severity of dystonia in hamsters when administered prior to the age of maximum severity of dystonia." | 3.68 | Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters. ( Fredow, G; Löscher, W, 1992) |
| "From among 1377 patients with movement disorders, four patients had an unusual movement disorder characterised by paroxysmal bursts of involuntary, regular, repetitive, rhythmic, bilateral, coordinated, simultaneous, stereotypic myoclonus and vocalisations, often associated with tonic symptoms, interference with voluntary functioning, presence of hyperactivity, attention and learning disabilities, and resistance to treatment with haloperidol and other drugs." | 3.67 | Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes? ( Feinberg, TE; Shapiro, AK; Shapiro, E, 1986) |
| " Therefore, we have studied the effect of different 5-HT drugs and one anticholinergic drug in acute dystonia in five cebus monkeys chronically treated with haloperidol." | 3.67 | Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys. ( Gerlach, J; Korsgaard, S; Laursen, AL; Noring, U; Povlsen, UJ, 1986) |
| " In this retrospective study, 15 of 16 young adult patients treated only with haloperidol had such reactions within 60 hours of beginning the drug, while none of the seven patients treated with haloperidol plus prophylactic benztropine mesylate developed dystonia." | 3.67 | Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions. ( Bakalar, NH; Boyer, WF; Lake, CR, 1987) |
| "The use of baclofen, a structural analog of gamma-aminobutyric acid (GABA), is described in the treatment of a patient with tardive dystonia." | 3.67 | Baclofen treatment in a patient with tardive dystonia. ( Allen, A; Lux, WE; Rosse, RB, 1986) |
| " SCH 23390 (a selective D1 antagonist) and raclopride (a selective D2 antagonist) induced identical syndromes consisting of dystonia and oral dyskinesia." | 3.67 | Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans. ( Gerlach, J; Kistrup, K, 1987) |
| " To clarify the etiology of neuroleptic-induced acute dystonic reactions, monkeys (Cercopithecus aethiops) were treated with haloperidol at doses sufficient to evoke dystonia, and the effects of agents that influenced dopaminergic, cholinergic, or GABAergic neurotransmitters were evaluated." | 3.66 | Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. ( Casey, DE; Christensson, E; Gerlach, J, 1980) |
| " Case 1 is a description of the subjective experience of a patient with acute orofacial dystonia from promethazine." | 3.66 | Case vignettes of movement disorders. ( Yung, CY, 1983) |
| " Sample size was reduced from 311 to 156 patients, thereby decreasing the number of patients exposed to placebo from 54 to 30 and the number exposed to the active control with a known side effect from 126 to 60." | 2.74 | Bayesian adaptive non-inferiority with safety assessment: retrospective case study to highlight potential benefits and limitations of the approach. ( Baker, R; Breier, A; Dunayevich, E; Lindborg, S; Seaman, J; Spann, M, 2009) |
| "We have presented pharmacokinetic parameters of bromperidol (BP) in 14 healthy Korean subjects." | 2.72 | Pharmacokinetic parameters of bromperidol in Korean subjects. ( Kim, HG; Kim, JW; Kim, YG; Lee, SY, 2006) |
| "An eleven-fold increase in dystonia was found in patients who received no prophylactic medication." | 2.65 | Benztropine prophylaxis of dystonic reactions. ( Anderson, WH; Stern, TA, 1979) |
| "Antipsychotic-induced laryngeal dystonia is a life-threatening side-effect of both high- and low-potency classical antipsychotics, and its diagnosis often remains elusive." | 2.43 | Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review. ( Christodoulou, C; Kalaitzi, C, 2005) |
| "Risperidone has these pharmacologic properties." | 2.39 | Extrapyramidal side effects and tolerability of risperidone: a review. ( Owens, DG, 1994) |
| "Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man." | 2.37 | Acute dystonia induced by neuroleptic drugs. ( Jenner, P; Marsden, CD; Rupniak, NM, 1986) |
| "Most cases of acute dystonia are mild and easy to manage; nevertheless, some of them can be fatal because of the involvement of certain muscle groups such as the laryngeal muscles, thus requiring urgent intervention." | 1.39 | Is acute dystonia an emergency? Sometimes, it really is! ( Cizmeci, MN; Derinoz, O; Havali, C; Kanburoglu, MK, 2013) |
| "Oromandibular dystonia is a subtype of dystonia which can present with perioral manifestations." | 1.38 | Bilateral dislocation of temporomandibular joint induced by haloperidol following suicide attempt: a case report. ( Arghand Dargahi, M; Tabatabaiefar, MA; Taslimi, S; Zakariaei, Z, 2012) |
| "Depressed levels of consciousness and dystonia were the most common presenting signs, present in 90." | 1.31 | Phenothiazine, butyrophenone, and other psychotropic medication poisonings in children and adolescents. ( Abel, K; James, LP; Nichols, MH; Simpson, PM; Wilkinson, J, 2000) |
| "Acute dystonia developed in 10 of 33 patients, and the mean age was significantly lower (P < 0." | 1.31 | The characteristics of side-effects of bromperidol in schizophrenic patients. ( Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Tanaka, O; Yasui-Furukori, N, 2002) |
| "Dopa-responsive dystonia, an autosomal-dominant disorder caused by mutations in the guanosine triphosphate (GTP)-cyclohydrolase I gene, is characterized by severe striatal dopamine depletion." | 1.30 | Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia. ( de la Fuente-Fernández, R, 1998) |
| "Tardive dystonia is a difficult condition to treat." | 1.30 | Treatment of tardive dystonia with an antispastic agent. ( Ishiguro, T; Nisijima, K; Shimizu, M, 1998) |
| "Extrapyramidal symptoms (EPS) of dystonia and sedation were scored daily." | 1.29 | The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys. ( Casey, DE, 1995) |
| "One of the patients developed dystonia 24 hours after ingestion of 750 mg tetrabenazine in an attempt at suicide." | 1.29 | [Drug-induced dystonia misinterpreted as hysteria]. ( Dietrichs, E; Magnusson, A; Opjordsmoen, S, 1996) |
| "Haloperidol and perphenazine induced dystonia in the same way as sigma receptor agonists, whereas zotepine and (-)-sulpiride did not." | 1.29 | BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats. ( Akiyama, K; Kuroda, S; Okumura, K; Ujike, H, 1996) |
| "This form of dystonia is called tardive dystonia to distinguish it from tardive dyskinesia." | 1.29 | [Tardive dystonia. A rare neuroleptic-induced disease picture]. ( Assion, HJ; Heinemann, F, 1994) |
| "Neither (-)-3-PPP nor SND 919 produced dystonia, but had observable dopamine D2 receptor agonistic effects, (-)-3-PPP producing emesis at 1-4 mg/kg and SND 919 producing motoric unrest and stereotypy at 0." | 1.29 | Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol. ( Gerlach, J; Peacock, L, 1993) |
| "Haloperidol was implicated in 47 patients (37%), followed by amitriptyline/perphenazine in 30%, thioridazine in 27%, and chlorpromazine in 20%." | 1.28 | Neurologic approach to drug-induced movement disorders: a study of 125 patients. ( Jankovic, J; Miller, LG, 1990) |
| "Then at the age of eight, she developed dystonia of the left lower extremity that became noticeable toward evening but subsided after taking sleep." | 1.28 | [Response to haloperidol and analysis of growth curve in hereditary progressive dystonia with marked diurnal fluctuation]. ( Cho, K; Kusunoki, Y; Oki, J; Sasaki, N, 1989) |
| "Rhabdomyolysis is a rarely reported complication of antipsychotic drug-induced dystonia." | 1.27 | Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs. ( Cavanaugh, JJ; Finlayson, RE, 1984) |
| " Data were analyzed to determine the effect of anticholinergic prophylaxis, age, sex, and type and dosage of neuroleptic on the incidence of dystonic reactions." | 1.27 | Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. ( Heiser, JF; Morrison, RL; Simpson, GM; Sramek, JJ, 1986) |
| "Attacks of acute dystonia have been noticed in all animals, sometimes necessitating anticholinergic medication or decreases in the daily haloperidol dose." | 1.26 | Development of acute dystonia and tardive dyskinesia in cebus monkeys. ( Bárány, S; Gunne, LM; Ingvast, A, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (35.71) | 18.7374 |
| 1990's | 41 (36.61) | 18.2507 |
| 2000's | 20 (17.86) | 29.6817 |
| 2010's | 10 (8.93) | 24.3611 |
| 2020's | 1 (0.89) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, JW | 1 |
| Chapa, A | 1 |
| Kockara, N | 1 |
| Helminiak, A | 1 |
| Vaz, AS | 1 |
| Brito, N | 1 |
| Moura, L | 1 |
| Fernandes, A | 1 |
| Ostinelli, EG | 1 |
| Brooke-Powney, MJ | 1 |
| Li, X | 1 |
| Adams, CE | 3 |
| Masiran, R | 1 |
| Kanburoglu, MK | 1 |
| Derinoz, O | 1 |
| Cizmeci, MN | 1 |
| Havali, C | 1 |
| Bergman, H | 1 |
| Irving, CB | 1 |
| Lawrie, S | 1 |
| Rasmussen, SA | 1 |
| Rosebush, PI | 1 |
| Mazurek, MF | 1 |
| Ridout, KK | 1 |
| Ridout, SJ | 1 |
| Peek, DF | 1 |
| Spann, M | 1 |
| Lindborg, S | 1 |
| Seaman, J | 1 |
| Baker, R | 1 |
| Dunayevich, E | 1 |
| Breier, A | 1 |
| Chen, L | 2 |
| Wang, HT | 1 |
| Han, XH | 1 |
| Li, YL | 1 |
| Cui, QL | 2 |
| Xie, JX | 2 |
| Yagmur, F | 1 |
| Ulusoy, HB | 1 |
| Buyukoglan, H | 1 |
| Kaya, MG | 1 |
| Zakariaei, Z | 1 |
| Taslimi, S | 1 |
| Tabatabaiefar, MA | 1 |
| Arghand Dargahi, M | 1 |
| Powney, MJ | 1 |
| Jones, H | 1 |
| Torner, C | 1 |
| Herrera-Estrella, M | 1 |
| Gutiérrez, JA | 1 |
| Aguilar-Roblero, R | 1 |
| FIERLAFIJN, E | 1 |
| Barnes Recker, CK | 1 |
| Hoehns, JD | 1 |
| Sutherland, JE | 1 |
| Opheim, EF | 1 |
| Jhee, SS | 1 |
| Zarotsky, V | 1 |
| Mohaupt, SM | 1 |
| Yones, CL | 1 |
| Sims, SJ | 1 |
| Hamann, M | 1 |
| Meisler, MH | 1 |
| Richter, A | 3 |
| Martínez Fernández, G | 1 |
| Plaza Moral, A | 1 |
| Miró Descarga, P | 1 |
| Arguís Gimeno, MJ | 1 |
| Gomar Sancho, C | 1 |
| Christodoulou, C | 1 |
| Kalaitzi, C | 1 |
| Chakravarty, A | 1 |
| Lee, SY | 1 |
| Kim, YG | 1 |
| Kim, HG | 1 |
| Kim, JW | 1 |
| Xue, Y | 1 |
| Yung, WH | 1 |
| Praharaj, SK | 1 |
| Arora, M | 1 |
| Sari, A | 1 |
| Akkaya, C | 1 |
| Taskapilioglu, O | 1 |
| Erer, S | 1 |
| Bora, I | 1 |
| Gross, ML | 1 |
| Stahl, SM | 1 |
| Berger, PA | 1 |
| Fritze, J | 1 |
| Conn, LM | 1 |
| Lion, JR | 1 |
| Campbell, M | 1 |
| Small, AM | 1 |
| Green, WH | 1 |
| Jennings, SJ | 1 |
| Perry, R | 1 |
| Bennett, WG | 1 |
| Anderson, L | 1 |
| McKeon, TW | 1 |
| Lorden, JF | 2 |
| Oltmans, GA | 1 |
| Beales, M | 1 |
| Walkley, SU | 1 |
| Yung, CY | 1 |
| Ortiz, A | 1 |
| Castillo, J | 1 |
| Castro, A | 1 |
| Dapena, D | 1 |
| Arias, M | 1 |
| Colell, S | 1 |
| Lema, M | 1 |
| Noya, M | 1 |
| Cavanaugh, JJ | 1 |
| Finlayson, RE | 1 |
| Casey, DE | 4 |
| Gerlach, J | 4 |
| Christensson, E | 1 |
| Town, IG | 1 |
| McDanal, CE | 1 |
| Bryant, SG | 1 |
| Menuck, M | 1 |
| Owens, DG | 1 |
| van't Groenewout, JL | 1 |
| Stone, MR | 1 |
| Vo, VN | 2 |
| Truong, DD | 2 |
| Matsumoto, RR | 3 |
| Factor, SA | 1 |
| Podskalny, GD | 1 |
| Barron, KD | 1 |
| Assion, HJ | 1 |
| Heinemann, F | 1 |
| Capstick, C | 1 |
| Checkley, S | 1 |
| Gray, J | 1 |
| Dawe, S | 1 |
| Aguilar, EJ | 1 |
| Keshavan, MS | 1 |
| Martínez-Quiles, MD | 1 |
| Hernández, J | 1 |
| Gómez-Beneyto, M | 1 |
| Schooler, NR | 1 |
| Khanna, R | 1 |
| Damodaran, SS | 1 |
| Chakraborty, SP | 1 |
| Peacock, L | 1 |
| Löscher, W | 3 |
| Kastrup, O | 1 |
| Gastpar, M | 1 |
| Schwarz, M | 1 |
| Lindenmeyer, JP | 1 |
| Magnusson, A | 1 |
| Opjordsmoen, S | 1 |
| Dietrichs, E | 1 |
| Tarsy, D | 1 |
| Miyawaki, E | 1 |
| Bowen, WD | 2 |
| Walker, JM | 2 |
| Patrick, SL | 1 |
| Zambon, AC | 1 |
| De Costa, BR | 1 |
| Rice, KC | 1 |
| Raja, M | 1 |
| Maisto, G | 1 |
| Altavista, MC | 1 |
| Albanese, A | 1 |
| Okumura, K | 1 |
| Ujike, H | 1 |
| Akiyama, K | 1 |
| Kuroda, S | 1 |
| Fang, J | 1 |
| Beasley, CM | 1 |
| Tollefson, GD | 1 |
| Tran, PV | 1 |
| Modrego Pardo, P | 1 |
| Pérez Trullen, JM | 1 |
| Fukuoka, T | 1 |
| Nakano, M | 1 |
| Kohda, A | 1 |
| Okuno, Y | 1 |
| Matsuo, M | 1 |
| Ilchef, R | 1 |
| de la Fuente-Fernández, R | 1 |
| Black, KJ | 1 |
| Racette, B | 1 |
| Perlmutter, JS | 1 |
| Nisijima, K | 1 |
| Shimizu, M | 1 |
| Ishiguro, T | 1 |
| Gannon, MA | 1 |
| O'Sullivan, P | 1 |
| Fines, RE | 1 |
| Brady, WJ | 1 |
| Martin, ML | 1 |
| Rojas, VM | 1 |
| Davies, RK | 1 |
| Miwa, H | 1 |
| Nishi, K | 1 |
| Fuwa, T | 1 |
| Mizuno, Y | 1 |
| James, LP | 1 |
| Abel, K | 1 |
| Wilkinson, J | 1 |
| Simpson, PM | 1 |
| Nichols, MH | 1 |
| Vogler, CM | 1 |
| Szonyli, G | 1 |
| Munro, P | 1 |
| Cusack, S | 1 |
| Yasui-Furukori, N | 1 |
| Kondo, T | 1 |
| Ishida, M | 1 |
| Tanaka, O | 1 |
| Mihara, K | 1 |
| Kaneko, S | 1 |
| Otani, K | 1 |
| Hendrickson, RG | 1 |
| Morocco, AP | 1 |
| Greenberg, MI | 1 |
| Stern, TA | 1 |
| Anderson, WH | 1 |
| Bárány, S | 1 |
| Ingvast, A | 1 |
| Gunne, LM | 1 |
| Calne, DB | 1 |
| Eisler, T | 1 |
| Godwin-Austen, RB | 1 |
| Cavenar, JO | 1 |
| Hammett, EB | 1 |
| Maltbie, A | 1 |
| Lee, AS | 1 |
| Di Monda, V | 1 |
| Fazzari, G | 1 |
| Callea, L | 1 |
| Adlmici, G | 1 |
| Sinaniotis, CA | 1 |
| Spyrides, P | 1 |
| Vlachos, P | 1 |
| Papadatos, C | 1 |
| Suzuki, E | 1 |
| Kanba, S | 1 |
| Nibuya, M | 1 |
| Shintani, F | 1 |
| Kinoshita, N | 1 |
| Yagi, G | 1 |
| Asai, M | 1 |
| Fredow, G | 1 |
| Meltzer, LT | 1 |
| Christoffersen, CL | 1 |
| Serpa, KA | 1 |
| Pugsley, TA | 1 |
| Razmpour, A | 1 |
| Heffner, TG | 1 |
| Lauterbach, EC | 1 |
| Verhoeff, NP | 1 |
| Wasserstein, PH | 1 |
| Honig, LS | 1 |
| Sandyk, R | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| Remington, GJ | 1 |
| Voineskos, G | 1 |
| Pollock, B | 1 |
| Reed, K | 1 |
| Coulter, K | 1 |
| Stevens, CB | 1 |
| Friedman, EH | 1 |
| Mackler, S | 1 |
| Moskowitz, M | 1 |
| Oki, J | 1 |
| Sasaki, N | 1 |
| Kusunoki, Y | 1 |
| Cho, K | 1 |
| Heintz, R | 1 |
| Yashar, AG | 1 |
| Walker, FO | 1 |
| Rupniak, NM | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Sramek, JJ | 1 |
| Simpson, GM | 1 |
| Morrison, RL | 1 |
| Heiser, JF | 1 |
| Kumor, K | 1 |
| Sherer, M | 1 |
| Jaffe, J | 1 |
| Kistrup, K | 1 |
| Addonizio, G | 1 |
| Alexopoulos, GS | 1 |
| Davidson, M | 1 |
| Powchik, P | 1 |
| Davis, KL | 1 |
| Feinberg, TE | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Povlsen, UJ | 1 |
| Noring, U | 1 |
| Laursen, AL | 1 |
| Korsgaard, S | 1 |
| Conacher, GN | 1 |
| Marazki, MO | 1 |
| Evans, DA | 1 |
| Bertilsson, L | 1 |
| Sjoqvist, F | 1 |
| Boyer, WF | 1 |
| Bakalar, NH | 1 |
| Lake, CR | 1 |
| Rosse, RB | 1 |
| Allen, A | 1 |
| Lux, WE | 1 |
| Bateman, DN | 1 |
| Rawlins, MD | 1 |
| Simpson, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia[NCT00351936] | Phase 4 | 16 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluating change in Body Mass Index (BMI) between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | kg/m^2 (Mean) |
|---|---|
| Aripiprazole | -0.4 |
| Placebo | 0.3 |
Evaluating change in fasting total cholesterol between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | mg/dL (Mean) |
|---|---|
| Aripiprazole | -3 |
| Placebo | 9 |
Evaluating change in high-density lipoprotein cholesterol (HDL-C) between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | mg/dL (Mean) |
|---|---|
| Aripiprazole | 0.4 |
| Placebo | 0.6 |
Evaluating change in low-density lipoprotein (LDL) between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | mg/dL (Mean) |
|---|---|
| Aripiprazole | -0.2 |
| Placebo | 3.1 |
Evaluating change in triglyceride levels between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | mg/dL (Mean) |
|---|---|
| Aripiprazole | -51.7 |
| Placebo | 47.6 |
Evaluating change in waist-hip ratio (WHR) between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | cm (Mean) |
|---|---|
| Aripiprazole | 0.0 |
| Placebo | 0.0 |
Evaluating change in weight (lbs) between Baseline and Week 4, comparing subjects treated with aripiprazole for 4 weeks to subjects treated with placebo for 4 weeks. (NCT00351936)
Timeframe: baseline, week 4
| Intervention | lbs (Mean) |
|---|---|
| Aripiprazole | -2.9 |
| Placebo | 2.1 |
9 reviews available for haloperidol and Dystonia
| Article | Year |
|---|---|
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Dystonia; Haloperidol; Humans; Hypnotics and Sedatives; Placebos; | 2017 |
Haloperidol versus placebo for schizophrenia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Dystonia; Haloperidol; Humans; Parkinsonian Disorders | 2013 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazep | 2012 |
Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Dystonia; Female; Haloperidol; Humans; Larynge | 2005 |
Pharmacologic approaches to violence.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Be | 1984 |
Extrapyramidal side effects and tolerability of risperidone: a review.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; D | 1994 |
Safety of olanzapine.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Clini | 1997 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopami | 1979 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease M | 1986 |
7 trials available for haloperidol and Dystonia
| Article | Year |
|---|---|
Bayesian adaptive non-inferiority with safety assessment: retrospective case study to highlight potential benefits and limitations of the approach.
Topics: Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Double-Blind Method; Drug-Related Side Effects | 2009 |
Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Circadian Rhythm; Cros | 2003 |
Pharmacokinetic parameters of bromperidol in Korean subjects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A | 2006 |
Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dystonia; F | 1982 |
Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.
Topics: Aggression; Child; Child Behavior Disorders; Clinical Trials as Topic; Depressive Disorder; Double-B | 1984 |
Predictors of acute dystonia in first-episode psychotic patients.
Topics: Adolescent; Adult; Age Factors; Biperiden; Delusions; Double-Blind Method; Dystonia; Female; Haloper | 1994 |
Benztropine prophylaxis of dystonic reactions.
Topics: Adult; Aged; Antipsychotic Agents; Benztropine; Clinical Trials as Topic; Dystonia; Female; Haloperi | 1979 |
96 other studies available for haloperidol and Dystonia
| Article | Year |
|---|---|
Haloperidol-induced isolated lingual dystonia.
Topics: Adult; Dystonia; Dystonic Disorders; Female; Haloperidol; Humans | 2021 |
Involuntary movements in an adolescent: what are the causes?
Topics: Adolescent; Alcoholic Intoxication; Antipsychotic Agents; Biperiden; Dystonia; Emergency Service, Ho | 2019 |
Persistent oromandibular dystonia and angioedema secondary to haloperidol.
Topics: Adult; Angioedema; Antipsychotic Agents; Diagnosis, Differential; Dystonia; Haloperidol; Humans; Mal | 2017 |
Is acute dystonia an emergency? Sometimes, it really is!
Topics: Acute Disease; Adolescent; Antipsychotic Agents; Biperiden; Chlorpromazine; Diagnosis, Differential; | 2013 |
The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dyskinesia, Dr | 2017 |
Haloperidol-Associated Uterine Dystonia.
Topics: Antipsychotic Agents; Anxiety Disorders; Dystonia; Female; Haloperidol; Humans; Pregnancy; Uterine D | 2017 |
A patient with haloperidol induced laryngeal dystonia.
Topics: Antipsychotic Agents; Dystonia; Haloperidol; Humans; Laryngeal Diseases; Male; Middle Aged; Respirat | 2008 |
Behavioral and electrophysiological effects of pallidal GABAB receptor activation and blockade on haloperidol-induced akinesia in rats.
Topics: Animals; Baclofen; Behavior, Animal; Dopamine Antagonists; Dystonia; Electrophysiology; Excitatory P | 2008 |
Acute respiratory distress due to antipsychotic drugs.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Drug Therapy, Co | 2010 |
Bilateral dislocation of temporomandibular joint induced by haloperidol following suicide attempt: a case report.
Topics: Adolescent; Dopamine Antagonists; Dystonia; Female; Haloperidol; Humans; Joint Dislocations; Suicide | 2012 |
[HP 32, COMBINATION OF R 1625 (HALOPERIDOL) AND R 79 (ISOPROPAMIDE IODIDE) IN THE THERAPY OF PSYCHIC AND AUTONOMIC DYSTONIA].
Topics: Autonomic Nervous System Diseases; Dystonia; Dystonic Disorders; Haloperidol; Parasympatholytics; Ps | 1963 |
An online misadventure with haloperidol.
Topics: Acetaminophen; Administration, Oral; Adult; Azepines; Codeine; Drug Combinations; Dystonia; Female; | 2003 |
Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol.
Topics: Adult; Dystonia; Female; Haloperidol; Humans; Injections, Intramuscular; Ocular Motility Disorders; | 2003 |
Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Brain; Diazepam; Disease Models, Animal | 2003 |
[Acute dystonia due to haloperidol during labor].
Topics: Acute Disease; Adult; Dystonia; Female; Haloperidol; Humans; Obstetric Labor Complications; Pregnanc | 2004 |
Neuroleptic-induced acute laryngeal dystonia causing stridor: a lesson to remember.
Topics: Antipsychotic Agents; Dystonia; Haloperidol; Humans; Laryngeal Diseases; Male; Respiratory Sounds; S | 2005 |
Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; D | 2007 |
Pisa syndrome: acute and tardive forms.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Male; Schizoph | 2007 |
Laryngeal dystonia in a patient with bilateral anterior cerebral artery infarction during treatment of delirium with haloperidol.
Topics: Antipsychotic Agents; Delirium; Dystonia; Haloperidol; Humans; Infarction, Anterior Cerebral Artery; | 2008 |
Acute dystonia as idiosyncratic reaction to haloperidol.
Topics: Acute Disease; Child; Dystonia; Female; Haloperidol; Humans; Hypertension | 1980 |
Can neuroleptics influence the function of the brain hemispheres asymmetrically?
Topics: Animals; Antipsychotic Agents; Brain; Carotid Arteries; Clopenthixol; Dystonia; Flupenthixol; Functi | 1984 |
Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Catalepsy; Corpus Striatum; Dopamine; Dystonia; Golgi Appara | 1984 |
Case vignettes of movement disorders.
Topics: Adult; Amantadine; Brain Injuries; Clonazepam; Diagnosis, Differential; Dystonia; Female; Haloperido | 1983 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscle | 1983 |
[Clinical and electrophysiological study of idiopathic orofacial dystonia (Meige's disease or Brueghel syndrome)].
Topics: Dystonia; Electromyography; Facial Expression; Facial Muscles; Female; Haloperidol; Humans; Hyperkin | 1984 |
Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs.
Topics: Acute Disease; Adult; Dystonia; Haloperidol; Humans; Male; Muscles; Myoglobinuria; Psychotic Disorde | 1984 |
Dopamine, acetylcholine, and GABA effects in acute dystonia in primates.
Topics: Acetylcholine; Animals; Chlorocebus aethiops; Dopamine; Dystonia; gamma-Aminobutyric Acid; Haloperid | 1980 |
Haloperidol: neuroleptic malignant syndrome.
Topics: Adult; Dystonia; Haloperidol; Humans; Male; Muscle Rigidity; Syndrome | 1982 |
Haloperidol and laryngeal-pharyngeal dystonia.
Topics: Adult; Dystonia; Female; Haloperidol; Humans; Laryngeal Diseases; Pharyngeal Diseases | 1981 |
Street drug misrepresentation.
Topics: Adult; Diazepam; Drug-Related Side Effects and Adverse Reactions; Dystonia; Haloperidol; Humans; Ill | 1980 |
Laryngeal-pharyngeal dystonia and haloperidol.
Topics: Adult; Dystonia; Haloperidol; Humans; Laryngeal Muscles; Male; Muscles; Pharyngeal Muscles | 1981 |
Evidence for the involvement of histamine in the antidystonic effects of diphenhydramine.
Topics: Animals; Diphenhydramine; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Halope | 1995 |
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.
Topics: Adult; AIDS Dementia Complex; Antipsychotic Agents; Astrocytes; Atrophy; Brain; Cell Count; Dystonia | 1994 |
[Tardive dystonia. A rare neuroleptic-induced disease picture].
Topics: Basal Ganglia; Basal Ganglia Diseases; Drug Therapy, Combination; Dystonia; Electromyography; Female | 1994 |
Dystonia induced by amphetamine and haloperidol.
Topics: Adult; Amphetamine; Dose-Response Relationship, Drug; Drug Synergism; Dystonia; Female; Haloperidol; | 1994 |
Overflow movements may predict neuroleptic-induced dystonia.
Topics: Adolescent; Adult; Bipolar Disorder; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Male; | 1994 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; | 1993 |
The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol.
Topics: Animals; Clozapine; Cricetinae; Disease Models, Animal; Dystonia; Female; Haloperidol; Male; Mesocri | 1993 |
Acute dystonia due to clozapine.
Topics: Acute Disease; Biperiden; Clozapine; Dystonia; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1994 |
Precipitation of dystonia by m-CPP in a schizophrenic patient treated with haloperidol.
Topics: Dystonia; Haloperidol; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Serotonin; S | 1993 |
The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys.
Topics: Administration, Oral; Animals; Cebus; Dopamine Antagonists; Dystonia; Haloperidol; Lactose; Receptor | 1995 |
[Drug-induced dystonia misinterpreted as hysteria].
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Diagnosis, Differential; Dystonia; Female | 1996 |
Tardive dystonia after neuroleptic treatment of Tourette's syndrome.
Topics: Adult; Antipsychotic Agents; Dystonia; Haloperidol; Humans; Male; Tourette Syndrome | 1996 |
Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.
Topics: Aging; Animals; Central Nervous System Depressants; Dystonia; Haloperidol; Head Movements; In Vitro | 1996 |
Tardive lingual dystonia treated with clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Dystonia; Haloperidol; Humans; Male; Schizophrenia; Tongue | 1996 |
BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
Topics: Animals; Antipsychotic Agents; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonis | 1996 |
Hyperactive behavioural effects induced by intranigral infusion of a pyridinium metabolite of haloperidol in rats.
Topics: Animals; Behavior, Animal; Dystonia; Haloperidol; Hyperkinesis; Injections, Intraventricular; Male; | 1996 |
[Acute recurrent dystonia secondary to neuroleptic suppression].
Topics: Acute Disease; Antipsychotic Agents; Dystonia; Haloperidol; Humans; Male; Middle Aged; Recurrence; S | 1997 |
MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamsters.
Topics: Animals; Anti-Dyskinesia Agents; Catalepsy; Clozapine; Cricetinae; Dizocilpine Maleate; Drug Synergi | 1997 |
The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia.
Topics: Acute Disease; Animals; Antipsychotic Agents; Callithrix; Cholinergic Antagonists; Dose-Response Rel | 1997 |
Neuroleptic-induced laryngeal dystonia can mimic anaphylaxis.
Topics: Acute Disease; Adult; Anaphylaxis; Antipsychotic Agents; Diagnosis, Differential; Dystonia; Haloperi | 1997 |
Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia.
Topics: Adult; Anti-Dyskinesia Agents; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Family | 1998 |
Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Combined Modality Therapy; Contracture; Dystonia; Female; | 1998 |
Treatment of tardive dystonia with an antispastic agent.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Dystonia; Female; Haloperidol; Humans; Propiophenones; | 1998 |
Medical management of disturbed behaviour.
Topics: Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Depressive Disorder; Dysto | 1998 |
Acute laryngeal dystonia related to neuroleptic agents.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Diphenhydramine; Dystonia; Female; Halo | 1999 |
Reserpine treatment of comorbid Tourette's disorder and tardive dystonia.
Topics: Adrenergic Uptake Inhibitors; Adult; Comorbidity; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; H | 1999 |
Effects of blockade of metabotropic glutamate receptors in the subthalamic nucleus on haloperidol-induced Parkinsonism in rats.
Topics: Animals; Benzoates; Dopamine Antagonists; Dystonia; Excitatory Amino Acid Antagonists; Glycine; Halo | 2000 |
Phenothiazine, butyrophenone, and other psychotropic medication poisonings in children and adolescents.
Topics: Accidents, Home; Adolescent; Alabama; Antipsychotic Agents; Arkansas; Child; Child, Preschool; Dysto | 2000 |
Laryngeal dystonia secondary to neuroleptic medications.
Topics: Adult; Aged; Aged, 80 and over; Benztropine; Dopamine Antagonists; Dystonia; Female; Follow-Up Studi | 2001 |
Epidemic dystonia in Cork.
Topics: Adolescent; Adult; Benztropine; Dystonia; Female; Haloperidol; Humans; Illicit Drugs; Ireland; Male; | 2001 |
The characteristics of side-effects of bromperidol in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Dystonia; Female; Haloperidol; Humans; Hypokinesia; Male; Schizophrenia | 2002 |
Acute dystonic reactions to "street Xanax".
Topics: Adolescent; Adult; Alprazolam; Child; Dystonia; Female; Haloperidol; Humans; Illicit Drugs; Male | 2002 |
Development of acute dystonia and tardive dyskinesia in cebus monkeys.
Topics: Animals; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Haplorhini; Motor Activity; Time Factors | 1979 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement | 1979 |
Misdiagnosis of severe dystonia.
Topics: Adult; Cerebral Hemorrhage; Diagnosis, Differential; Diagnostic Errors; Dystonia; Female; Haloperido | 1979 |
Treatment of drug-induced dystonic reactions.
Topics: Adolescent; Adult; Benztropine; Diphenhydramine; Dystonia; Female; Haloperidol; Humans; Injections, | 1979 |
[On a muscular dystony case from manganism. Therapeutic clinic considerations (author's transl)].
Topics: Benserazide; Diazepam; Dystonia; Haloperidol; Humans; Hydrazines; Levodopa; Male; Manganese; Middle | 1979 |
Acute haloperidol poisoning in children.
Topics: Acute Disease; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Child; Child, Preschool; Dys | 1978 |
Use of pimozide in the Pisa syndrome.
Topics: Adult; Dystonia; Haloperidol; Humans; Male; Pimozide; Receptors, Opioid; Receptors, sigma; Schizophr | 1992 |
Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Carbidopa; Cricetinae; Dopamine; Drug Interac | 1992 |
Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; Dystonia; Electrophysiology; Halope | 1992 |
Haloperidol-induced dystonia and parkinsonism on discontinuing metoclopramide: implications for differential thalamocortical activity.
Topics: Adult; Brain; Drug Therapy, Combination; Dystonia; Female; Haloperidol; Humans; Metoclopramide; Park | 1992 |
[The suppressed pill with far-reaching consequences].
Topics: Dystonia; Haloperidol; Humans; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Tomography, E | 1992 |
Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys.
Topics: Animals; Behavior, Animal; Benzazepines; Cebus; Dopamine Antagonists; Dose-Response Relationship, Dr | 1992 |
Tic or dystonia?
Topics: Adult; Diagnosis, Differential; Dystonia; Haloperidol; Humans; Tic Disorders; Torticollis | 1992 |
Haloperidol-sensitive sigma receptor and the role of the pineal gland in dystonia.
Topics: Animals; Dystonia; Female; Haloperidol; Humans; Male; Pineal Gland; Rats; Receptors, Opioid; Recepto | 1991 |
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amitriptyline; Antipsychotic Agents; Chorea | 1990 |
Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug | 1990 |
Acute laryngeal dystonic reactions.
Topics: Adult; Dystonia; Haloperidol; Humans; Laryngeal Diseases; Male; Respiratory Insufficiency | 1990 |
Treatment of tardive dystonia.
Topics: Auditory Perceptual Disorders; Dystonia; Hallucinations; Haloperidol; Humans; Infant; Ocular Motilit | 1990 |
Tetanus or drug reaction?
Topics: Adult; Aged; Diagnosis, Differential; Dystonia; Haloperidol; Humans; Immunization, Passive; Male; Te | 1989 |
[Response to haloperidol and analysis of growth curve in hereditary progressive dystonia with marked diurnal fluctuation].
Topics: Body Height; Child; Circadian Rhythm; Dystonia; Female; Haloperidol; Humans; Levodopa | 1989 |
Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.
Topics: Animals; Basal Ganglia Diseases; Cebus; Corpus Striatum; Dopamine; Dystonia; Female; Haloperidol; Ma | 1987 |
Altered haloperidol-sensitive sigma receptors in the genetically dystonic (dt) rat.
Topics: Animals; Brain; Dystonia; Female; Haloperidol; Humans; In Vitro Techniques; Kinetics; Male; Rats; Ra | 1988 |
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Topics: Adolescent; Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Child; Chlorp | 1986 |
Haloperidol-induced dystonia in cocaine addicts.
Topics: Adult; Cocaine; Dystonia; Haloperidol; Humans; Male; Substance-Related Disorders | 1986 |
Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepi | 1987 |
Drug-induced dystonia in young and elderly patients.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Dystonia; Female; Fluphenazine; Halo | 1988 |
Pisa syndrome in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amantadine; Drug Therapy, Combination; Dystonia; Haloperidol; Humans; Male; | 1988 |
Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes?
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dystonia; Female; Haloperidol; Humans; Male; Move | 1986 |
Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys.
Topics: Animals; Biperiden; Cebus; Citalopram; Dose-Response Relationship, Drug; Dystonia; Haloperidol; Male | 1986 |
Acute dystonic reactions in Saudi Arabian psychiatric patients treated with haloperidol.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Dystonia; Europe; Haloperidol; Humans; Middle A | 1987 |
Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.
Topics: Acute Disease; Adult; Benztropine; Drug Therapy, Combination; Dystonia; Female; Haloperidol; Humans; | 1987 |
Baclofen treatment in a patient with tardive dystonia.
Topics: Aged; Alzheimer Disease; Baclofen; Dystonia; Female; Haloperidol; Humans | 1986 |
Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom.
Topics: Adolescent; Adult; Age Factors; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Dystonia; Female; | 1986 |